DCLK1 as a Promising Marker for Radioresistance in Colorectal Cancer

被引：3
|
作者：
Mohammadi, Chiman [1 ]
Najafi, Rezvan [1 ]
机构：
[1] Hamadan Univ Med Sci, Res Ctr Mol Med, Hamadan, Hamadan, Iran
来源：
JOURNAL OF GASTROINTESTINAL CANCER | 2020年 / 51卷 / 02期
关键词：
D O I：
10.1007/s12029-019-00292-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：714 / 715
页数：2
相关论文
共 50 条
  • [1] DCLK1 as a Promising Marker for Radioresistance in Colorectal Cancer
    Chiman Mohammadi
    Rezvan Najafi
    Journal of Gastrointestinal Cancer, 2020, 51 : 714 - 715
  • [2] The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer
    Vedeld, Hege Marie
    Skotheim, Rolf I.
    Lothe, Ragnhild A.
    Lind, Guro E.
    EPIGENETICS, 2014, 9 (03) : 346 - 350
  • [3] Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods
    Mirzaei, Alireza
    Madjd, Zahra
    Kadijani, Azade Amini
    Tavakoli-Yaraki, Masoumeh
    Modarresi, Mohammad Hossein
    Verdi, Javad
    Akbari, Abolfazl
    Tavoosidana, Gholamreza
    CANCER BIOMARKERS, 2016, 17 (03) : 301 - 311
  • [4] Therapeutic microRNA targeting DCLK1 against colorectal cancer
    Morimoto, Yoshihiro
    Inoue, Akira
    Ikeshima, Ryo
    Yokoyama, Yuhki
    Takahashi, Hidekazu
    Miyoshi, Norikatsu
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Mori, Masaki
    Yamamoto, Hirofumi
    CANCER SCIENCE, 2018, 109 : 1011 - 1011
  • [5] DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
    Mohammadi, Chiman
    Mahdavinezhad, Ali
    Saidijam, Massoud
    Bahreini, Fatemeh
    Pashaki, Abdolazim Sedighi
    Gholami, Mohammad Hadi
    Najafi, Rezvan
    INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 2021, 10 (01) : 23 - 33
  • [6] DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target
    Vanan, Ahmad Ghorbani
    Vesal, Soheil
    Seraj, Parmida
    Ghezel, Mohammad Amin
    Eini, Pooya
    Talebileili, Maryam
    Asgari, Zeynab
    Tahmasebi, Safa
    Hashemi, Mehrdad
    Taheriazam, Afshin
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (11) : 2068 - 2086
  • [7] Analysis of the clinical significance of DCLK1+ colorectal cancer using novel monoclonal antibodies against DCLK1
    Dai, Tianqi
    Hu, Yunlong
    Lv, Fulian
    Ozawa, Tatsuhiko
    Sun, Xin
    Huang, Jingjing
    Han, Xiaojian
    Kishi, Hiroyuki
    Muraguchi, Atsushi
    Jin, Aishun
    ONCOTARGETS AND THERAPY, 2018, 11 : 5047 - 5057
  • [8] DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer
    Tianbo Gao
    Min Wang
    Lingling Xu
    Tao Wen
    Jian Liu
    Guangyu An
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 2131 - 2140
  • [9] DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer
    Gao, Tianbo
    Wang, Min
    Xu, Lingling
    Wen, Tao
    Liu, Jian
    An, Guangyu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (10) : 2131 - 2140
  • [10] DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer
    Vijai, Muthu
    Baba, Mursaleen
    Ramalingam, Satish
    Thiyagaraj, Anand
    ONCOLOGY LETTERS, 2021, 22 (06)
12345